XTX Topco’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-24,416
Closed -$115K 2952
2024
Q3
$115K Buy
24,416
+9,257
+61% +$41.7K 0.01% 1582
2024
Q2
$58.4K Sell
15,159
-3,672
-19% -$16.6K 0.01% 1493
2024
Q1
$101K Sell
18,831
-4,939
-21% -$23.2K 0.01% 1364
2023
Q4
$101K Sell
23,770
-19,263
-45% -$59.2K 0.02% 1114
2023
Q3
$169K Buy
+43,033
New +$282K 0.03% 1071

Other funds holding TSVT

XTX Topco's TSVT Position: Q4 2024 in Review

XTX Topco sold out of 2seventy bio (TSVT) in Q4 2024, closing a stake of 24,416 shares — an estimated $115K sold.

XTX Topco first reported a position in TSVT in Q3 2023 and held it in 5 quarters. The position peaked at $169K in Q3 2023. 116 funds tracked by Wall St. Rank hold TSVT as of Q4 2024.

  • XTX Topco reported no remaining 2seventy bio position as of Q4 2024 after selling out during the quarter.
  • XTX Topco sold 24,416 2seventy bio shares in Q4 2024, an estimated $115K.
  • XTX Topco first reported a position in 2seventy bio in Q3 2023 and held it in 5 quarters.
  • XTX Topco's 2seventy bio position peaked at $169K in Q3 2023.
  • 116 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2024.

Based on XTX Topco's 13F filing for Q4 2024, filed 13 Feb 2025.